Microbot Medical Inc.
NASDAQ:MBOTMedical - Instruments & Supplies
-$0.06 today
- Market cap
- $65.73M
- Beta
- 1.04
- P/E (TTM)
- -8.6
- EPS (TTM)
- -$0.21
Volume 0.87M
Average 1.60M
MBOT Total Assets
Everything the company owns or controls; equal to total liabilities plus equity.
Microbot Medical Inc.NASDAQ: MBOT
Total Assets · Q1 FY2026 · quarter ended Mar 2026
Total assets rises 152.7% from a year ago
Total assets stood at $78.07M at the end of Q1 FY2026, up 152.7% from a year earlier and down 4.3% from the prior quarter. Over 3 fiscal years it compounded at +104.5% a year.
Context
- Total assets increased in 1 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether total assets keeps rising in the next quarterly balance sheet after a +152.7% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Assets history
USD · from the balance sheet
- Latest · FY2025
- 81.54M USD
- Year-over-year change
- +1252.1%
- 4-year CAGR
- +48.5%
| Period | Period end | Total Assets | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 81.54M | +1252.1% |
| FY2024 | 2024-12-31 | 6.03M | -27.6% |
| FY2023 | 2023-12-31 | 8.33M | -12.7% |
| FY2022 | 2022-12-31 | 9.54M | -43.1% |
| FY2021 | 2021-12-31 | 16.77M | — |
Total Assets vs competitors
How MBOT compares with its peers on the latest reported figures
- Peers report in different currencies, so total assets is compared through growth and rates rather than absolute size.
- Its year-over-year change of +152.7% is the 2nd highest of 10, against a peer median of -14.4%.
- Over three fiscal years its annual growth of +104.5% compares with a peer median of -16.9%.
| Company | Period | Latest balance | YoY | 3-year CAGR |
|---|---|---|---|---|
| Mar 2026 | $268.85M USD | +82.2% | +12.6% | |
| Mar 2026 | $225.63M USD | +176.3% | -0.9% | |
| Mar 2026 | $209.23M USD | -51.4% | -18.0% | |
| Mar 2026 | $78.07M USD | +152.7% | +104.5% | |
| Mar 2026 | $58.86M USD | -36.7% | +21.7% | |
| Mar 2026 | $51.54M USD | -25.9% | -16.9% | |
| Mar 2026 | $42.35M USD | +19.5% | -8.3% | |
| Mar 2026 | CA$31.49M CAD | +23.7% | -19.8% | |
| Mar 2026 | $21.67M USD | -14.4% | -25.9% | |
| Mar 2026 | CA$15.13M CAD | -17.8% | -23.1% | |
| Peer median (excluding MBOT) | — | -14.4% | -16.9% | |
Competitors are the stored peer set for MBOT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Microbot Medical Inc.
NASDAQ:MBOT
Intrinsic Alpha fair value
Locked
Current Price
$0.98
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.